Stefano Piaserico

InstitutionUniversity of Padua
AddressPadua
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 16 Covid-19 publications, with a maximum of 3 publications in June 2020
    All Publications
    Bar chart showing 111 publications over 21 distinct years, with a maximum of 14 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Piaserico S, Gisondi P, Cazzaniga S, Di Leo S, Naldi L. Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence. J Invest Dermatol. 2022 02; 142(2):355-363.e7. PMID: 34363826.
      Citations:    Fields:    
    2. Gisondi P, Cazzaniga S, Di Leo S, Piaserico S, Bellinato F, Pizzolato M, Gatti A, Eccher A, Brunelli M, Saraggi D, Girolomoni G, Naldi L. Impact of the COVID-19 pandemic on melanoma diagnosis. J Eur Acad Dermatol Venereol. 2021 Nov; 35(11):e714-e715. PMID: 34236721.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Gisondi P, Bellinato F, Piaserico S, Di Leo S, Cazzaniga S, Naldi L. Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs. Dermatol Ther (Heidelb). 2021 Aug; 11(4):1333-1343. PMID: 34173220.
      Citations:    
    4. Gisondi P, Di Leo S, Bellinato F, Cazzaniga S, Piaserico S, Naldi L. Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review. Dermatol Ther (Heidelb). 2021 Jun; 11(3):695-705. PMID: 33811315.
      Citations: 3     
    5. Gisondi P, Geat D, Naldi L, Piaserico S. Insights into Sars-CoV-2 vaccination in patients with chronic plaque psoriasis on systemic treatments. J Eur Acad Dermatol Venereol. 2021 Jun; 35(6):e361-e362. PMID: 33650226.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    6. Piaserico S, Gisondi P, Cazzaniga S, Cazzaniga S, Girolomoni G, Girolomoni G, Calzavara-Pinton PG, Naldi L. Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy? J Eur Acad Dermatol Venereol. 2021 Jun; 35(6):e355-e357. PMID: 33587774.
      Citations: 1     Fields:    Translation:Humans
    7. Gisondi P, Piaserico S, Bordin C, Bellinato F, Tozzi F, Alaibac M, Girolomoni G, Naldi L. The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events. Clin Exp Rheumatol. 2021 Sep-Oct; 39(5):1099-1107. PMID: 33635229.
      Citations: 1     Fields:    Translation:Humans
    8. Talamonti M, Galluzzo M, Chiricozzi A, Quaglino P, Fabbrocini G, Gisondi P, Marzano AV, Potenza C, Conti A, Parodi A, Piaserico S, Bardazzi F, Argenziano G, Rongioletti F, Stingeni L, Micali G, Loconsole F, Rossi MT, Bongiorno MR, Feliciani C, Rubegni P, Amerio P, Fargnoli MC, Pigatto P, Savoia P, Nisticò SP, Giustini S, Carugno A, Cannavo' SP, Rech G, Prignano F, Offidani A, Lombardo M, Zalaudek I, Bianchi L, Peris K. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. Expert Opin Biol Ther. 2021 02; 21(2):271-277. PMID: 33216643.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    9. Gisondi P, Piaserico S, Naldi L, Dapavo P, Conti A, Malagoli P, Marzano AV, Bardazzi F, Gasperini M, Cazzaniga S, Costanzo A. Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience. J Allergy Clin Immunol. 2021 Feb; 147(2):558-560.e1. PMID: 33160968.
      Citations: 13     Fields:    Translation:Humans
    10. Piaserico S, Gisondi P, Cazzaniga S, Naldi L. Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy. Am J Clin Dermatol. 2020 10; 21(5):749-751. PMID: 32812188.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    11. Messina F, Pampaloni F, Piaserico S. Correspondence on 'Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a patient with COVID-19 with psoriatic arthritis receiving ustekinumab'. Ann Rheum Dis. 2021 05; 80(5):e79. PMID: 32816688.
      Citations: 4     Fields:    Translation:Humans
    12. Gisondi P, PIaserico S, Bordin C, Alaibac M, Girolomoni G, Girolomoni G, Naldi L. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update. J Eur Acad Dermatol Venereol. 2020 Nov; 34(11):2499-2504. PMID: 32585074.
      Citations: 21     Fields:    Translation:HumansPHPublic Health
    13. Piaserico S, Meneguzzo A, Messina F. REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19. J Infect. 2020 09; 81(3):e37-e38. PMID: 32610110.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    14. Messina F, Piaserico S. SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor. J Eur Acad Dermatol Venereol. 2020 Jun; 34(6):e254-e255. PMID: 32294258.
      Citations: 20     Fields:    Translation:HumansPHPublic Health
    15. Gisondi P, Piaserico S, Conti A, Naldi L. Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice. J Eur Acad Dermatol Venereol. 2020 Jun; 34(6):1196-1201. PMID: 32320091.
      Citations: 28     Fields:    Translation:HumansPHPublic Health
    16. Gisondi P, Facheris P, Dapavo P, Piaserico S, Conti A, Naldi L, Cazzaniga S, Cazzaniga S, Malagoli P, Costanzo A. The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience. Br J Dermatol. 2020 08; 183(2):373-374. PMID: 32343839.
      Citations: 38     Fields:    Translation:HumansCellsPHPublic Health
    Piaserico's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (182)
    Explore
    _
    Co-Authors (68)
    Explore
    _
    Similar People (60)
    Explore
    _